Wikidata

(Q34743609)

English

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

scientific article

In more languages

Statements

title
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18235121
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18235121%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34743609&oldid=2119138587"